(8) Individualized Use: CV Risk, Age, and Bleeding Must Guide: In primary prevention, the net clinical benefit of aspirin lies in carefully balancing ischemic versus bleeding risk ... “Aspirin in the ...

Primary Endpoint of 12-month EFS: Interim Analysis of Ongoing Secondary Endpoint, OS: Post-Hoc Analyses 12-months EFS Subgroup Analysis in the OST-HER2 Treatment Group: Gender (Males vs Females ...

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are prescribed as primary and secondary ... prevention clinic, but that women remain less likely to achieve their treatment goals ...

Background and purpose: Clinicians have suggested that those who get an implantable cardioverter defibrillator (ICD) for primary prevention vs. secondary prevention experience significantly different ...

16 This study was performed to examine the efficacy and safety of evolocumab added to moderate- or high-intensity statin therapy for secondary prevention in patients with ASCVD. The primary efficacy .

Primary and secondary osteoarthritis are similar ... A 2021 study suggests that all people may benefit from a lifelong prevention strategy to help protect the joints.

our data demonstrate that the separation of primary vs. secondary prevention based on history of ASCVD is overly simplified.” In external validation with a cohort of 5,322 participants in the ...

In addition, Song underscored the distinction between primary and secondary prevention, noting that there was some confusion ... Low-dose aspirin didn’t reduce the risk of first strokes of any type (4 ...

Clinicians have a new standard for graft-versus-host disease (GVHD) prevention after allogeneic ... Patients achieved the primary endpoint if they were alive, without acute GVHD grade III-IV ...

Although promising candidates are in development for the secondary prevention of Lp(a)-mediated cardiovascular disease, it will be many years before these candidates are assessed for primary ...

BARCELONA, Spain—(UPDATED) Aspirin has long been the antiplatelet of choice for long-term secondary prevention in patients with coronary ... in patients who were taking a P2Y12 inhibitor alone versus ...